BCAT2 and bladder transitional cell carcinoma: According to outcomes of bulk RNA‐seq, scRNA‐seq, and vitro experiment, we demonstrated that BCAT2 plays an immunosuppressive role in BLCA by suppressing recruitment and cytotoxicity of CD8+T cells.